Medicine guide
Avandamet
·
- Prescription status not stated
- Digestion, stomach, diabetes and nutrition
- Active substance
- Rosiglitazone;metformin
- Made by
- SmithKline Beecham Plc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- AVANDAMET is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients: who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone. in triple oral therapy with sulphonylurea in patients with insufficient glycaemic control despite dual oral therapy with their maximally tolerated dose of metformin and a sulphonylurea (see section 4.4).
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | SmithKline Beecham Plc |
|---|---|
| Active substance | Rosiglitazone;metformin |
| Used in | Digestion, stomach, diabetes and nutrition |
| Classification | A10BD03 · Digestion, stomach, diabetes and nutrition |
| Authorised on | 2003-10-20 |
| Last updated by the regulator | 2016-06-08 |
| EMA product number | EMEA/H/C/000522 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).